ARCHIVES

Reviewers Note Major Flaws In Design Of Burzynski’s Trials

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

Fifty-Nine CCOP Awards Made; Payline 250, Six Funded as Exceptions

May 27, 1983

In Brief: Sparano Named Vice Chair of ECOG-ACRIN

May 17, 2013

NCCS Networker Volume 10 Issue 3, Winter 1996

January 13, 1996

Drug Approvals: FDA Approves Vectibix in mCRC With KRAS Companion Diagnostic

May 30, 2014

ODAC Recommends Ethyol, DaunoXome For FDA Approval

June 16, 1995

In Brief: Appropriations Bill Hung Up In Senate; Paul Black To Head B.U. Humphrey Center

September 21, 1979